Dr. Zan Dai is a multidisciplinary researcher specializing in nanomedicine, cancer immunotherapy, and biomaterials engineering. He earned his Ph.D. in Biomedical Engineering from The University of Queensland in 2022, where he developed immunomodulating nanomedicines to enhance cancer immunotherapy. During his postdoctoral fellowship at The University of Queensland, Dr. Dai led projects focused on innovative therapeutic strategies, including...view more
Dr. Zan Dai is a multidisciplinary researcher specializing in nanomedicine, cancer immunotherapy, and biomaterials engineering. He earned his Ph.D. in Biomedical Engineering from The University of Queensland in 2022, where he developed immunomodulating nanomedicines to enhance cancer immunotherapy. During his postdoctoral fellowship at The University of Queensland, Dr. Dai led projects focused on innovative therapeutic strategies, including nanoparticle-based drug delivery systems, while mentoring Ph.D. students and fostering interdisciplinary collaborations.
Currently, at the Children’s Cancer Institute, Dr. Dai’s research centers on lipid nanoparticles and CAR-T cell technology for treating brain tumors and aggressive pediatric cancers. His work addresses critical challenges in therapeutic delivery and efficacy, advancing the development of safer, more effective treatments for these challenging diseases.
My Qualifications
Ph.D., Biomedical Engineering, University of Queensland, 2022
M.S., Chemical Engineering, Wuhan Institute of Technology (China), 2016
My Awards
2023 Molecular Systems Design & Engineering ECR Oral Presentation Prize, Royal Society of Chemistry
2022 Outstanding Self-Financed Chinese Students Abroad, China
2018 Australia International Ph.D. Scholarship, Australia.
2015 National Postgraduate Scholarship, China.
https://orcid.org/0000-0002-7821-4629